Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.90 -0.05 (-5.32%)
As of: Oct 1, 2026 · 2:15 PM EDT

Lineage Cell Therapeutics (LCTX) Other Operating Expenses (2011 - 2025)

Updated

Lineage Cell Therapeutics (LCTX) posted Other Operating Expenses of $66,000 for Q4 2025, down 57.1% from $154,000 a year earlier.

Analysis

Lineage Cell Therapeutics (LCTX) Other Operating Expenses (2011 - 2025) Analysis & Trends

For FY2025, Lineage Cell Therapeutics' Other Operating Expenses came in at $146,000, down 56.3% from FY2024.

  • In prior years, Lineage Cell Therapeutics' Other Operating Expenses was $334,000 in FY2024 (-50.2%) and $671,000 in FY2023.
  • Quarterly Other Operating Expenses has run from a low of $5,000 in Q3 2025 to a high of $169,000 in Q3 2023 over five years.
  • On a year-over-year basis, Other Operating Expenses has declined in each of the last four quarters, with an average decline of 54.2% over the last seven quarters.
  • According to Business Quant data, Other Operating Expenses for the three prior quarters was $5,000 (Q3 2025), $39,000 (Q2 2025) and $36,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lineage Cell Therapeutics 240.26 Mn 38.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 66,000.00
Sep 30, 2025 5,000.00
Jun 30, 2025 39,000.00
Mar 31, 2025 36,000.00
Dec 31, 2024 154,000.00
Sep 30, 2024 38,000.00
Jun 30, 2024 44,000.00
Mar 31, 2024 98,000.00
Sep 30, 2023 169,000.00
Jun 30, 2023 127,000.00
Mar 31, 2023 119,000.00
Dec 31, 2018 -108,000.00
Mar 31, 2018 800,000.00
Dec 31, 2015 2,000.00
Dec 31, 2014 12,000.00
Mar 31, 2014 436.00
Dec 31, 2013 97.00
Dec 31, 2012 4,279.00
Dec 31, 2011 -12,656.00
API Access

Lineage Cell Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=LCTX&period=max&api_key=YOUR_API_KEY